MAGL-IN-4

Overview

MAGL-IN-4 is an orally active, selective and reversible monoacylglycerol lipase ( MAGL ) inhibitor with an IC 50 of 6.2 nM. MAGL-IN-4 can penetrate the blood-brain barrier (BBB). MAGL-IN-4 enhances endocannabinoid signaling mostly by the increase in the level of 2-AG via selective MAGL inhibition in the brain.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > MAGL

Product Information

• Catalog No.: HY-132310
• CAS No.: 2135785-20-3
• Molecular Formula: C18H21ClN2O4
• Molecular Weight: 364.82
• Purity: 99.79%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (6.85 mM); Clear solution
• Availability: In-stock

Source

Original product source